This case is a trading situation arising from the acquisition of Ranbaxy Laboratories Limited, an Indian pharmaceutical company to Daiichi Sankyo, Inc, a Japanese pharmaceutical company in 2008. After the buyout of the founding family in the company Ranbaxy, Daiichi Sankyo made part time offer to acquire the remaining shares of Ranbaxy. Uncertainty as to whether or not the deal will take place and what the possible speed of decision is a result of the special situation investment opportunities. In the case, the risk arbitrageur is necessary to evaluate this potential, and to determine the appropriate trading strategy. Key decisions include whether to buy or sell shares of the target and when to implement the purchase or sale. Thus, the case is a developing situation added a rich set of relevant secondary data, such as news and stock prices, so that the students get acquainted with the real situation of trade. The case requires students to understand market mechanisms and a detailed analysis to justify its decision. "Hide
by Rama Seth, P. Srikant Ayyar Source: Richard Ivey School of Business Foundation 12 pages. Publication Date: December 04, 2012. Prod. #: W12357-PDF-ENG
Related Case Solutions & Analyses:
Campbells Soup Company
Cold Stone Creamery
Toyota: Accelerator Pedal Recall (B)
RBC – Financing Oil Sands (B)
Replacing El Poderoso
YM Biosciences
Surgery With Blunt Tools: Restructuring and Ambiguity at Umbra Health Partners
Cenabal (A)
City Furniture and Mattress (B)
Kodaks Health Imaging Division in Asia (B): The Crisis in Thailand
